EU strikes treat Moderna for up to 160 million vaccine doses

The European Union has reached an agreement with the American biotechnology company Moderna on the delivery of up to 160 million doses of its Covid-19 vaccine candidate, the President of the Commission said on Tuesday.

The deal will be formally approved by the EU’s CEO on Wednesday, said European Commission President Ursula von der Leyen.

“According to the results of clinical trials, this vaccine can be very effective against Covid-19. Once the vaccine has proven to be safe and effective, all Member States will receive it at the same time on a pro rata basis,” said von sa der Leyen.

Last week, Moderna said its experimental vaccine was 94.5% effective in preventing Covid-19, based on interim data from a late-stage clinical trial.

In August, the EU Commission, which jointly leads talks with vaccine manufacturers on behalf of Member States, said preliminary talks with Moderna had been concluded with a view to signing an agreement to supply 80 million doses of its vaccine, with the possibility of buying another 80 million. .

( Jowharwith AFP and REUTERS)

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More